Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy
✍ Scribed by Kar Neng Lai; Loretta Y. Y. Chan; Hong Guo; Sydney C. W. Tang; Joseph C. K. Leung
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 917 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Peroxisome proliferator‐activated receptor γ (PPARγ) agonists cause cell death in several types of cancer cells. The aim of this study was to examine the effects of two PPARγ agonists, ciglitazone and 15‐deoxy‐Δ ^12,14^‐prostaglandin J2 (15dPGJ2), on the survival of thyroid carcinoma CG
## Abstract Gliomas are the most commonly diagnosed malignant brain primary tumors. Prognosis of patients with high‐grade gliomas is poor and scarcely affected by radiotherapy and chemotherapy. Several studies have reported antiproliferative and/or differentiating activities of some lipophylic mole